Svoboda | Graniru | BBC Russia | Golosameriki | Facebook
NasdaqGS - Delayed Quote USD

Clover Health Investments, Corp. (CLOV)

Compare
1.2500 +0.0300 (+2.46%)
At close: July 3 at 1:00 PM EDT
1.2600 +0.01 (+0.80%)
After hours: July 3 at 4:56 PM EDT
Loading Chart for CLOV
DELL

Clover Health Investments, Corp. Overview Healthcare Plans / Healthcare

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.

www.cloverhealth.com/en/

552

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CLOV

View More

Performance Overview: CLOV

Trailing total returns as of 7/3/2024, which may include dividends or other distributions. Benchmark is

S&P 500
.

YTD Return

CLOV
31.30%
S&P 500
16.08%

1-Year Return

CLOV
39.35%
S&P 500
24.42%

3-Year Return

CLOV
89.33%
S&P 500
27.22%

5-Year Return

CLOV
87.59%
S&P 500
82.06%

Compare To: CLOV

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CLOV

View More

Valuation Measures

Annual
As of 7/3/2024
  • Market Cap

    620.55M

  • Enterprise Value

    281.79M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.29

  • Price/Book (mrq)

    2.12

  • Enterprise Value/Revenue

    0.14

  • Enterprise Value/EBITDA

    -0.65

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -7.77%

  • Return on Assets (ttm)

    -7.78%

  • Return on Equity (ttm)

    -50.95%

  • Revenue (ttm)

    2.06B

  • Net Income Avi to Common (ttm)

    -156.83M

  • Diluted EPS (ttm)

    -0.3200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    342.35M

  • Total Debt/Equity (mrq)

    1.48%

  • Levered Free Cash Flow (ttm)

    35.65M

Research Analysis: CLOV

View More

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: CLOV

People Also Watch